6851 - 6875 of 8444 Results
Title
Year
- Physiological, pathological, and engineered cell identity reprogramming in the central nervous system2016RESTRICTEDTitle: Physiological, pathological, and engineered cell identity reprogramming in the central nervous systemJournal Name: WIREs Developmental BiologyPublisher: WileyVol: 5Issue #: 4Start Page: 499End Page: 517Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/wdev.234Best OA location URL: https://europepmc.org/articles/pmc4911333?pdf=renderCitation Count: 7
- Subliminal gait initiation deficits in rapid eye movement sleep behavior disorder: A harbinger of freezing of gait?2016OPENTitle: Subliminal gait initiation deficits in rapid eye movement sleep behavior disorder: A harbinger of freezing of gait?Journal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 11Start Page: 1711End Page: 1719Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26665Best OA location URL: https://europepmc.org/articles/pmc5115956?pdf=renderCitation Count: 41
-
RESTRICTEDTitle: The mitochondrial kinase PINK1: functions beyond mitophagyJournal Name: Journal of NeurochemistryPublisher: WileyVol: 139Issue #: S1Start Page: 232End Page: 239Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.13655Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13655Citation Count: 77
- Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson’s Disease2016RESTRICTEDTitle: Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson’s DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 13Issue #: 3Start Page: 635End Page: 646Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-016-0449-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-016-0449-z.pdfCitation Count: 17
-
RESTRICTEDTitle: Neuroscience Training for the 21st CenturyJournal Name: NeuronPublisher: Elsevier BVVol: 90Issue #: 5Start Page: 917End Page: 926Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2016.05.030Best OA location URL: http://www.cell.com/article/S0896627316302094/pdfCitation Count: 59
- Structural Brain Alterations Associated with Rapid Eye Movement Sleep Behavior Disorder in Parkinson’s Disease2016OPENTitle: Structural Brain Alterations Associated with Rapid Eye Movement Sleep Behavior Disorder in Parkinson’s DiseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep26782Best OA location URL: https://www.nature.com/articles/srep26782.pdfCitation Count: 117
-
OPENTitle: Two-Pore Channels and Parkinson's Disease: Where's the Link?Journal Name: MessengerPublisher: American Scientific PublishersVol: 5Issue #: 1Start Page: 67End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1166/msr.2016.1051Best OA location URL: https://europepmc.org/articles/pmc5436604?pdf=renderCitation Count: 7
-
OPENTitle: Histone H3 acetylation in the postmortem Parkinson’s disease primary motor cortexJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 627Issue #:Start Page: 121End Page: 125Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2016.05.060Best OA location URL: https://europepmc.org/articles/pmc5067161?pdf=renderCitation Count: 55
- A review of disease progression models of Parkinson's disease and applications in clinical trials2016RESTRICTEDTitle: A review of disease progression models of Parkinson's disease and applications in clinical trialsJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 7Start Page: 947End Page: 956Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26644Best OA location URL: https://europepmc.org/articles/pmc4931998?pdf=renderCitation Count: 47
- JUMPg: An Integrative Proteogenomics Pipeline Identifying Unannotated Proteins in Human Brain and Cancer Cells2016OPENTitle: JUMPg: An Integrative Proteogenomics Pipeline Identifying Unannotated Proteins in Human Brain and Cancer CellsJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 15Issue #: 7Start Page: 2309End Page: 2320Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.6b00344Best OA location URL: https://europepmc.org/articles/pmc5033046?pdf=renderCitation Count: 83
-
RESTRICTEDTitle: Motor subtype in Parkinson's disease: Different disorders or different stages of disease?Journal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 7Start Page: 957End Page: 961Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26657Citation Count: 91
- Cerebrospinal Fluid Amyloid β<sub>1-42</sub>, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson’s Disease2016RESTRICTEDTitle: Cerebrospinal Fluid Amyloid β<sub>1-42</sub>, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson’s DiseaseJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 9Issue #: 2Start Page: 89End Page: 96Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.16017Best OA location URL: https://doi.org/10.14802/jmd.16017Citation Count: 20
-
OPENTitle: Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in VivoJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 11Issue #: 8Start Page: 2105End Page: 2111Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.6b00217Best OA location URL: https://europepmc.org/articles/pmc4992440?pdf=renderCitation Count: 66
- Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease2016OPENTitle: Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's DiseaseJournal Name: Antioxidants & Redox SignalingPublisher: Mary Ann Liebert IncVol: 25Issue #: 18Start Page: 967End Page: 982Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1089/ars.2015.6598Best OA location URL: https://www.liebertpub.com/doi/pdf/10.1089/ars.2015.6598Citation Count: 38
-
RESTRICTEDTitle: Vagal neurocircuitry and its influence on gastric motilityJournal Name: Nature Reviews Gastroenterology & HepatologyPublisher: Springer Science and Business Media LLCVol: 13Issue #: 7Start Page: 389End Page: 401Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nrgastro.2016.76Best OA location URL: https://europepmc.org/articles/pmc5605144?pdf=renderCitation Count: 201
-
OPENTitle: Inflammatory profile in LRRK2-associated prodromal and clinical PDJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-016-0588-5Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-016-0588-5Citation Count: 66
- A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease2016RESTRICTEDTitle: A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 9Start Page: 1373End Page: 1380Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26659Citation Count: 126
-
OPENTitle: Cautionary optimism: caffeine and Parkinson’s disease riskJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-016-0037-8Best OA location URL: https://clinicalmovementdisorders.biomedcentral.com/track/pdf/10.1186/s40734-016-0037-8Citation Count: 5
-
OPENTitle: LRRK2 Regulates Voltage-Gated Calcium Channel FunctionJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2016.00035Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2016.00035/pdfCitation Count: 51
- Objective characterization of daily living transitions in patients with Parkinson’s disease using a single body-fixed sensor2016RESTRICTEDTitle: Objective characterization of daily living transitions in patients with Parkinson’s disease using a single body-fixed sensorJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 263Issue #: 8Start Page: 1544End Page: 1551Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-016-8164-6Citation Count: 46
- Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's disease2016OPENTitle: Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's diseaseJournal Name: Progress in Neuro-Psychopharmacology and Biological PsychiatryPublisher: Elsevier BVVol: 70Issue #:Start Page: 77End Page: 84Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.pnpbp.2016.05.004Best OA location URL: https://europepmc.org/articles/pmc5410378?pdf=renderCitation Count: 25
- Parkinson's disease-related network topographies characterized with resting state functional MRI2016OPENTitle: Parkinson's disease-related network topographies characterized with resting state functional MRIJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 2Start Page: 617End Page: 630Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23260Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118197Citation Count: 68
-
OPENTitle: Central Hypoventilation in Progressive Supranuclear PalsyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 1Start Page: 42End Page: 45Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12348Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12348Citation Count: 6
- Pure Autonomic Failure Versus Prodromal Dysautonomia in Parkinson's Disease: Insights from the Bedside2016OPENTitle: Pure Autonomic Failure Versus Prodromal Dysautonomia in Parkinson's Disease: Insights from the BedsideJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 1Start Page: 141End Page: 144Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12360Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12360Citation Count: 11
- Dentate nucleus iron deposition is a potential biomarker for tremor‐dominant Parkinson's disease2016OPENTitle: Dentate nucleus iron deposition is a potential biomarker for tremor‐dominant Parkinson's diseaseJournal Name: NMR in BiomedicinePublisher: WileyVol: 30Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/nbm.3554Best OA location URL: https://europepmc.org/articles/pmc4906439?pdf=renderCitation Count: 54